Myriad Genetics acquires Counsyl for $375m

Myriad Genetics some hours ago announced that it has acquired for $375m Counsyl, a company that develops and markets non-invasive screening systems to determine whether fetuses risk to develop  genetic diseases. Myriad Genetics–headquartered in Salt Lake City-is a leader in molecular diagnostics and in the so-called personalized medicine. The acquisition strengthens its position in the pre-natal diagnostics business.

(Source: Myriad Genetics)